Zacks' 7 Best Stocks for July, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 06/19/2013

Company Name Symbol %Change
SUPPORTCOM I SPRT
3.97%
SUMITOMO MIT SMFG
3.50%
HOOKER FURNI HOFT
3.31%
NIPPON TELEG NTT
2.87%
INGLES MARKE IMKTA
2.87%

Rating Action on MetLife Europe

by Zacks Equity Research

June 29, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

As per media sources, Standard & Poor's Ratings Services (“S&P”) confirmed its long-term financial strength rating and counterparty credit ratings of 'A+' on MetLife Europe Ltd. (“MEL”), a subsidiary of American Life Insurance Co. (“ALICO”), which is an operating subsidiary of MetLife Inc. (MET - Analyst Report). The outlook remains stable.

These rating affirmations came on the back of MEL’s strong credit portfolio, solid positioning in the U.K. variable annuity markets, strong capitalization and better investment profile. S&P is also looking forward to solid results being delivered by the MEL as a subsidiary of MetLife. However, lack of multiple business lines and the prevalent sluggish environment of the industry continue to be headwind in the path of the company’s growth.

MEL will play a substantial role in MetLife’s international growth, especially in the markets in U.K as both the company and ALICO are listed to be marketed by it. The rating agency expects MEL's sales of variable annuities to exceed GBP 800 million while intense competition and regulatory issues will weigh on the sales of pension and protection products.

Alongside, MEL constitutes a very small part of MetLife and represents less than 5% of ALICO’s generally accepted accounting principles (GAAP) capital and is far below the consolidated capital of the parent company.

According to the expectations of the agency, if MEL continuously receives MetLife’s support as it is doing presently, it can better its capital position and maintain a stable risk profile, leading to volume growth. It also expects the company to perform well beyond 2013.

Even though the rating agency is less likely to increase its current ratings, it expects the company to register solid operating results with an increase in total sales. However, the ratings might be downgraded if MetLife decides to divest MEL, if there is a sharp decline in its profitability or growth prospects, or if MetLife discontinues its capital support to MEL.

MetLife currently retains a Zacks #2 Rank, which translates into a short-term Buy rating. We also maintain a long-term Neutral recommendation on its stock.

American International Group Inc. (AIG - Analyst Report), one of the closest competitors of MetLife scores equally well with the rating agencies. Last month, Fitch Ratings reiterated Issuer Default Rating (IDR) of 'BBB' on the company with a positive outlook and the Insurer Financial Strength ratings of ‘A’ on its operating units with a stable outlook.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.